The Extracellular RNA Communication Consortium has published 700+ research articles since its inception in 2013. Most of our work is in the fields of extracellular RNA and extracellular vesicle biology, but the ERCC has also supported work in related areas like cancer signaling, RNA structure, and the function of microRNAs inside the cell. Those articles are listed here in reverse chronological order. You can browse different article categories using the drop-down menu at the top of the page.
Quesenberry P et al.
Hematopoietic stem cells: Uncomfortable considerations.
Curr Mol Biol Rep (2017) 3:165-171.
Webster NJ et al.
Testicular germ cell tumors arise in the absence of sex-specific differentiation.
Development (2021) 148.
Chen L et al.
Anal Chem (2021) 93:6456-6462.
Tulpule A et al.
Kinase-mediated RAS signaling via membraneless cytoplasmic protein granules.
Cell (2021) 184:2649-2664.e18.
Kunert-Graf JM, Sakhanenko NA & Galas DJ.
Optimized permutation testing for information theoretic measures of multi-gene interactions.
BMC Bioinformatics (2021) 22:180.
Yu X et al.
J Raman Spectrosc (2020) 51:432-441.
Li J et al.
Angiotensin II-induced muscle atrophy via PPARgamma suppression is mediated by miR-29b.
Mol Ther Nucleic Acids (2021) 23:743-756.
Chen C et al.
Nat Commun (2021) 12:1118.
Palace SG et al.
Yersinia pestis escapes entrapment in thrombi by targeting platelet function.
J Thromb Haemost (2020) 18:3236-3248.
Guo C et al.
The D614G mutation enhances the lysosomal trafficking of SARS-CoV-2 spike.
bioRxiv AOP 2020-12-09.
Ezzaty Mirhashemi M et al.
The dynamic platelet transcriptome in obesity and weight loss.
Arterioscler Thromb Vasc Biol (2021) 41:854-864.
Kunert-Graf J, Sakhanenko N & Galas D.
Entropy (Basel) (2020) 22:1333.
Su Y et al.
Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19.
Cell (2020) 183:1479-1495.e20.
Muralidharan K et al.
TERT promoter mutation analysis for blood-based diagnosis and monitoring of gliomas.
Clin Cancer Res (2021) 27:169-178.
Charest A.
Adv Biosyst (2020) 4:e2000069.
Chen B et al.
The long noncoding RNA CCAT2 induces chromosomal instability through BOP1 – AURKB signaling.
Gastroenterology (2020) 159:2146-2162.e33.
Meabon JS et al.
J Neurol Sci (2020) 417:117049.
Li F et al.
Cancers (Basel) (2020) 12:2041.
Chiu LS et al.
Liver Int (2020) 40:2445-2454.
Lurie E et al.
Chen F et al.
J Cell Mol Med (2020) 24:7378-7392.
Zhang L et al.
A cell-phone-based acoustofluidic platform for quantitative point-of-care testing.
ACS Nano (2020) 14:3159-3169.
Kang P et al.
Lab Chip (2020) 20:987-994.
Xiong C et al.
Targeting forward and reverse EphB4/EFNB2 signaling by a peptide with dual functions.
Sci Rep (2020) 10:520.
Parashar D et al.
Cell Rep (2019) 29:4389-4406.e10.
Lee J et al.
Rational design of a bifunctional AND-gate ligand to modulate cell-cell interactions.
ACS Synth Biol (2020) 9:191-197.
Darling CE et al.
JMIR Cardio (2017) 1:e1.
Ding EY et al.
JMIR Cardio (2019) 3:e13850.
Wu D et al.
Cell Host Microbe (2019) 26:638-649.e5.
Spartano NL et al.
JMIR Mhealth Uhealth (2019) 7:e13238.
Dias MM et al.
GLS2 is protumorigenic in breast cancers.
Oncogene (2020) 39:690-702.
Yoneshiro T et al.
BCAA catabolism in brown fat controls energy homeostasis through SLC25A44.
Nature (2019) 572:614-619.
Batki J et al.
The nascent RNA binding complex SFiNX licenses piRNA-guided heterochromatin formation.
Nat Struct Mol Biol (2019) 26:720-731.
Bach DH, Zhang W & Sood AK.
Chromosomal instability in tumor initiation and development.
Cancer Res (2019) 79:3995-4002.
Divakaran S et al.
Diagnostic accuracy of advanced imaging in cardiac sarcoidosis.
Circ Cardiovasc Imaging (2019) 12:e008975.
Xie W et al.
Proc Natl Acad Sci U S A (2019) 116:11946-11955.
Bayraktar R, Bertilaccio MTS & Calin GA.
The interaction between two worlds: microRNAs and Toll-Like Receptors.
Front Immunol (2019) 10:1053.
Zheng L et al.
Hatchet ribozyme structure and implications for cleavage mechanism.
Proc Natl Acad Sci U S A (2019) 116:10783-10791.
Zelniker TA et al.
J Am Heart Assoc (2019) 8:e011444.
Koupenova M et al.
The role of platelets in mediating a response to human influenza infection.
Nat Commun (2019) 10:1780.
Ma S et al.
GnRH-R-targeted lytic peptide sensitizes BRCA wild-type ovarian cancer to PARP inhibition.
Mol Cancer Ther (2019) 18:969-979.
Shah R, Murthy V & Freedman JE.
Nuts, cardiovascular health, and diabetes.
Circ Res (2019) 124:825-826.
Ko D et al.
Proteomics profiling and risk of new-onset atrial fibrillation: Framingham Heart Study.
J Am Heart Assoc (2019) 8:e010976.
Roh JD et al.
Activin type II receptor signaling in cardiac aging and heart failure.
Sci Transl Med (2019) 11:482.
Mazzu YZ et al.
miR-193b regulates tumorigenesis in liposarcoma cells via PDGFR, TGFbeta, and Wnt signaling.
Sci Rep (2019) 9:3197.
Grani C et al.
J Cardiovasc Magn Reson (2019) 21:14.
Liu B et al.
Interplay between miRNAs and host genes and their role in cancer.
Brief Funct Genomics (2018) 18:255-266.
Bei Y et al.
Cathelicidin-related antimicrobial peptide protects against myocardial ischemia/reperfusion injury.
BMC Med (2019) 17:42.
Carrero I et al.
Oncogene (2019) 38:3551-3568.
Usmani SM et al.
Cell Host Microbe (2019) 25:73-86.e5.
LaFargue CJ et al.
Exploring and comparing adverse events between PARP inhibitors.
Lancet Oncol (2019) 20:e15-e28.
Shah RV et al.
Arterioscler Thromb Vasc Biol (2019) 39:107-115.
Cortez MA et al.
Role of miRNAs in immune responses and immunotherapy in cancer.
Genes Chromosomes Cancer (2019) 58:244-253.
Related Pathway
Ge XA & Hunter CP.
Efficient homologous recombination in mice using long single stranded DNA and CRISPR Cas9 nickase.
G3 (2019) 9:281-286.
Jia N et al.
Mol Cell (2019) 73:264-277.e5.
Chen B et al.
Efficient labeling and imaging of protein-coding genes in living cells using CRISPR-Tag.
Nat Commun (2018) 9:5065.
Zhou S et al.
Life Sci Alliance (2018) 1:e201800029.
Related Pathway
Vita T et al.
JACC Cardiovasc Imaging (2019) 12:1659-1669.
Villar-Prados A et al.
Predicting novel therapies and targets: Regulation of Notch3 by the bromodomain protein BRD4.
Mol Cancer Ther (2019) 18:421-436.
Suryawanshi H et al.
A single-cell survey of the human first-trimester placenta and decidua.
Sci Adv (2018) 4:eaau4788.
Wei S et al.
Rapid preimplantation genetic screening using a handheld, nanopore-based DNA sequencer.
Fertil Steril (2018) 110:910-916.e2.
Hisamatsu T et al.
PRKRA/PACT expression promotes chemoresistance of mucinous ovarian cancer.
Mol Cancer Ther (2019) 18:162-172.
Lu Y et al.
Stem Cells (2018) 36:1875-1889.
Shen P et al.
Mol Oncol (2018) 12:1856-1870.
Monroig-Bosque PDC et al.
OncomiR-10b hijacks the small molecule inhibitor linifanib in human cancers.
Sci Rep (2018) 8:13106.
Roy S et al.
Gastroenterology (2018) 155:1951-1966.e26.
Onuchic V et al.
Allele-specific epigenome maps reveal sequence-dependent stochastic switching at regulatory loci.
Science (2018) 361:1354.
Jun HJ et al.
Nat Commun (2018) 9:3116.
Related Pathway
Gharpure KM et al.
FABP4 as a key determinant of metastatic potential of ovarian cancer.
Nat Commun (2018) 9:2923.
Related Pathway
Umamaheswaran S et al.
Stress, inflammation, and eicosanoids: an emerging perspective.
Cancer Metastasis Rev (2018) 37:203-211.
Moustafa AA et al.
MicroRNAs in prostate cancer: From function to biomarker discovery.
Exp Biol Med (2018) 243:817-825.
Badawi M et al.
Oncotarget (2018) 9:26032-26045.
Lyons YA et al.
Immune cell profiling in cancer: Molecular approaches to cell-specific identification.
NPJ Precis Oncol (2017) 1:26.
Yeung TL et al.
J Natl Cancer Inst (2019) 111:272-282.
Gyorgy B et al.
Mol Ther Nucleic Acids (2018) 11:429-440.
Quinn JF.
Lost in translation? Finding our way to effective Alzheimer’s Disease therapies.
J Alzheimers Dis (2018) 64:S33-S39.
Staerk L et al.
BMJ (2018) 361:k1453.
Marangoni F et al.
J Immunol (2018) 200:3647-3661.
Smith AS et al.
Proc Natl Acad Sci USA (2018) 115:E4377-E4385.
Sardana M et al.
J Am Heart Assoc (2018) 7:7.
Shah MY et al.
Genome Res (2018) 28:432-447.
Andersen MS et al.
Shock (2019) 51:147-152.
Wei S, Weiss ZR & Williams Z.
Rapid multiplex small DNA sequencing on the MinION Nanopore sequencing platform.
G3 (Bethesda) (2018) 8:1649-1657.
Rodriguez Cetina Biefer H et al.
Mast cells regulate CD4(+) T-cell differentiation in the absence of antigen presentation.
J Allergy Clin Immunol (2018) 142:1894-1908.e7.
Velazquez-Torres G et al.
A-to-I miR-378a-3p editing can prevent melanoma progression via regulation of PARVA expression.
Nat Commun (2018) 9:461.
Viswanath P et al.
Cancer Res (2018) 78:2290-2304.
Koupenova M et al.
Circulating platelets as mediators of immunity, inflammation, and thrombosis.
Circ Res (2018) 122:337-351.
Related Pathway
Hulsmans M et al.
Cardiac macrophages promote diastolic dysfunction.
J Exp Med (2018) 215:423-440.
Related Pathway
McKenzie JA et al.
The effect of topoisomerase I inhibitors on the efficacy of T-cell-based cancer immunotherapy.
J Natl Cancer Inst (2018) 110:777-786.
Kanlikilicer P et al.
Mol Ther Nucleic Acids (2017) 9:251-262.
Soni A et al.
BMJ Open (2017) 7:e017668.
Boussiotis VA & Charest A.
Immunotherapies for malignant glioma.
Oncogene (2018) 37:1121-1141.
Noh K et al.
Differential effects of EGFL6 on tumor versus wound angiogenesis.
Cell Rep (2017) 21:2785-2795.
Vannini I et al.
Nat Commun (2017) 8:1801.
Related Pathway
Lu Y et al.
MYC targeted long noncoding RNA DANCR promotes cancer in part by reducing p21 levels.
Cancer Res (2018) 78:64-74.
Singh PB et al.
J Exp Med (2017) 214:3627-3643.
Ren A, Micura R & Patel DJ.
Structure-based mechanistic insights into catalysis by small self-cleaving ribozymes.
Curr Opin Chem Biol (2017) 41:71-83.
Zheng L et al.
Structure-based insights into self-cleavage by a four-way junctional twister-sister ribozyme.
Nat Commun (2017) 8:1180.
Bhakta NR et al.
IFN-stimulated gene expression, type 2 inflammation, and endoplasmic reticulum stress in asthma.
Am J Respir Crit Care Med (2018) 197:313-324.
Mitamura T et al.
Induction of anti-VEGF therapy resistance by upregulated expression of microseminoprotein (MSMP).
Oncogene (2018) 37:722-731.
Related Pathway
Piao X et al.
RNA (2018) 24:67-76.
Xiao J et al.
miR-31a-5p promotes postnatal cardiomyocyte proliferation by targeting RhoBTB1.
Exp Mol Med (2017) 49:e386.
Gerstberger S et al.
Cell Rep (2017) 21:758-772.
Lu Y et al.
Nat Med (2017) 23:1331-1341.
Grinberg YY, Zitzow LA & Kraig RP.
Intranasally administered IGF-1 inhibits spreading depression in vivo.
Brain Res (2017) 1677:47-57.
Shen P et al.
To Wnt or lose: The missing non-coding linc in colorectal cancer.
Int J Mol Sci (2017) 18:9.
Related Pathway
Rodriguez-Aguayo C et al.
Cell Discov (2017) 3:17029.
Dalton HJ et al.
Macrophages facilitate resistance to anti-VEGF therapy by altered VEGFR expression.
Clin Cancer Res (2017) 23:7034-7046.
Fleming ND et al.
Gynecol Oncol (2017) 147:41-46.
August P & Suthanthiran M.
Sex and kidney transplantation: Why can’t a woman be more like a man?
J Am Soc Nephrol (2017) 28:2829-2831.
Sardana M et al.
J Am Soc Echocardiogr (2017) 30:904-912.e2.
Fabris L & Calin GA.
Understanding the genomic ultraconservations: T-UCRs and cancer.
Int Rev Cell Mol Biol (2017) 333:159-172.
Denizli M et al.
Chitosan nanoparticles for miRNA delivery.
Methods Mol Biol (2017) 1632:219-230.
Sarkar S et al.
PRKCI promotes immune suppression in ovarian cancer.
Genes Dev (2017) 31:1109-1121.
Montoya MM et al.
A distinct inhibitory function for miR-18a in Th17 cell differentiation.
J Immunol (2017) 199:559-569.
Farmer DT et al.
Defining epithelial cell dynamics and lineage relationships in the developing lacrimal gland.
Development (2017) 144:2517-2528.
Aldrugh S et al.
Atrial fibrillation, cognition and dementia: A review.
J Cardiovasc Electrophysiol (2017) 28:958-965.
Li J et al.
miR-29b contributes to multiple types of muscle atrophy.
Nat Commun (2017) 8:15201.
Rigoutsos I et al.
N-BLR, a primate-specific non-coding transcript, leads to colorectal cancer invasion and migration.
Genome Biol (2017) 18:98.
Farmer DT et al.
miR-205 is a critical regulator of lacrimal gland development.
Dev Biol (2017) 427:12-20.
Nikan M et al.
Bioconjug Chem (2017) 28:1758-1766.
Montoya MM & Ansel KM.
Small RNA transfection in primary human Th17 cells by next generation electroporation.
J Vis Exp (2017) 122:e55546.
Camarda R, Williams J & Goga A.
In vivo reprogramming of cancer metabolism by MYC.
Front Cell Dev Biol (2017) 5:35.
Rabinowicz N et al.
Oncotarget (2017) 8:27380-27392.
Roh J, Houstis N & Rosenzweig A.
Why don’t we have proven treatments for HFpEF?
Circ Res (2017) 120:1243-1245.
Putman TE et al.
Database (Oxford) (2017) 2017:1.
Soni A et al.
Glob Health Sci Pract (2017) 5:152-163.
Wagner MJ et al.
Preclinical mammalian safety studies of EPHARNA (DOPC nanoliposomal EphA2-targeted siRNA).
Mol Cancer Ther (2017) 16:1114-1123.
Shi J et al.
Theranostics (2017) 7:664-676.
Khvorova A & Watts JK.
The chemical evolution of oligonucleotide therapies of clinical utility.
Nat Biotechnol (2017) 35:238-248.
Yeo AT & Charest A.
Immune checkpoint blockade biology in mouse models of glioblastoma.
J Cell Biochem (2017) 118:2516-2527.
Anderton B et al.
EMBO Rep (2017) 18:569-585.
Gladek I et al.
HIF1A gene polymorphisms and human diseases: Graphical review of 97 association studies.
Genes Chromosomes Cancer (2017) 56:439-452.
Modi A et al.
Validation of two point-of-care tests against standard lab measures of NO in saliva and in serum.
Nitric Oxide (2017) 64:16-21.
Heydari B, Harris WS & Kwong RY.
Circulation (2017) 135:e13-e14.
Krzeszinski JY et al.
Lipid osteoclastokines regulate breast cancer bone metastasis.
Endocrinology (2017) 158:477-489.
Van Roosbroeck K et al.
Combining anti-miR-155 with chemotherapy for the treatment of lung cancers.
Clin Cancer Res (2017) 23:2891-2904.
Moustafa AA et al.
Identification of microRNA signature and potential pathway targets in prostate cancer.
Exp Biol Med (Maywood) (2017) 242:536-546.
Pi F et al.
Nanomedicine (2017) 13:1183-1193.
Previs RA et al.
The rise of genomic profiling in ovarian cancer.
Expert Rev Mol Diagn (2016) 16:1337-1351.
Yang L et al.
Cell Metab (2016) 24:685-700.
Hatakeyama H et al.
Role of CTGF in sensitivity to hyperthermia in ovarian and uterine cancers.
Cell Rep (2016) 17:1621-1631.
Shah R, Pico AR & Freedman JE.
Translational epidemiology: Entering a brave new world of team science.
Circ Res (2016) 119:1060-1062.
Ohtsuka M et al.
EBioMedicine (2016) 13:113-124.
Mangala LS et al.
Improving vascular maturation using noncoding RNAs increases antitumor effect of chemotherapy.
JCI Insight (2016) 1:e87754.
Soni A et al.
JMIR Public Health Surveill (2016) 2:e159.
Giza DE et al.
Cellular and viral microRNAs in sepsis: Mechanisms of action and clinical applications.
Cell Death Differ (2016) 23:1906-1918.
Related Pathway
Tao L et al.
Crucial role of miR-433 in regulating cardiac fibrosis.
Theranostics (2016) 6:2068-2083.
Zhou J et al.
Clin Cancer Res (2017) 23:1945-1954.
Huang Y et al.
Anti-tumor and anti-angiogenic effects of aspirin-PC in ovarian cancer.
Mol Cancer Ther (2016) 15:2894-2904.
Sardana M et al.
J Cardiovasc Electrophysiol (2016) 27:1411-1419.
Harjes U et al.
Antiangiogenic and tumour inhibitory effects of downregulating tumour endothelial FABP4.
Oncogene (2017) 36:912-921.
Ciccone M & Calin GA.
MicroRNAs in chronic lymphocytic leukemia: An old disease with new genetic insights.
MicroRNA (2016) 5:106-112.
Related Pathway
Walkey AJ et al.
JAMA Cardiol (2016) 1:682-90.
Miranda F et al.
Cancer Cell (2016) 30:273-289.
Anfossi S & Calin GA.
Hodgkin lymphoma cells have a specific long noncoding RNA expression pattern.
Am J Pathol (2016) 186:2251-3.
Wang JH et al.
BMC Cancer (2016) 16:524.
Zhao Z et al.
Mol Cell Biol (2016) 36:2514-23.
Gao P et al.
Cell Res (2016) 26:901-13.
Bezzerides VJ et al.
CITED4 induces physiologic hypertrophy and promotes functional recovery after ischemic injury.
JCI Insight (2016) 1:9.
Ren A et al.
Pistol ribozyme adopts a pseudoknot fold facilitating site-specific in-line cleavage.
Nat Chem Biol (2016) 12:702-8.
Parasramka MA & Patel T.
Stem Cell Investig (2016) 3:1.
Henninger N et al.
Stroke (2016) 47:1486-92.
Chaluvally-Raghavan P et al.
Clarke D et al.
Identifying allosteric hotspots with dynamics: Application to inter- and intra-species conservation.
Structure (2016) 24:826-37.
Haemmerle M et al.
FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawal.
J Clin Invest (2016) 126:1885-96.
Ciccone M & Calin GA.
MicroRNAs in myeloid hematological malignancies.
Curr Genomics (2015) 16:336-48.
Yan KK et al.
Cross-disciplinary network comparison: Matchmaking between hairballs.
Cell Syst (2016) 2:147-157.
Pan Y et al.
Oncotarget (2016) 7:25930-48.
Putman TE et al.
Database (Oxford) (2016) 2016:baw028.
Huang J et al.
Dll4 inhibition plus aflibercept markedly reduces ovarian tumor growth.
Mol Cancer Ther (2016) 15:1344-52.
Burgstaller-Muehlbacher S et al.
Wikidata as a semantic framework for the Gene Wiki initiative.
Database (Oxford) (2016) 2016:baw015.
Rytelewski M et al.
Reciprocal positive selection for weakness – preventing olaparib resistance by inhibiting BRCA2.
Oncotarget (2016) 7:20825-39.
Olivieri M et al.
Oncotarget (2016) 7:20636-54.
Mora-Castilla S et al.
J Lab Autom (2016) 21:557-67.
Kundu A et al.
Am J Cardiol (2016) 117:1213-8.
Redis RS et al.
Allele-specific reprogramming of cancer metabolism by the long non-coding RNA CCAT2.
Mol Cell (2016) 61:520-34.
Pua HH et al.
Immunity (2016) 44:821-32.
Hansen JM, Coleman RL & Sood AK.
Targeting the tumour microenvironment in ovarian cancer.
Eur J Cancer (2016) 56:131-43.
Harmanci A & Gerstein M.
Quantification of private information leakage from phenotype-genotype data: linking attacks.
Nat Methods (2016) 13:251-6.
Guo P et al.
Biological nanomotors with a revolution, linear, or rotation motion mechanism.
Microbiol Mol Biol Rev (2016) 80:161-86.
Mitamura T, Gourley C & Sood AK.
Prediction and failure of anti-angiogenesis escape.
Gynecol Oncol (2016) 141:80-5.
Neophytou AM et al.
Am J Respir Crit Care Med (2016) 193:1271-80.
McManus DD et al.
Am J Cardiol (2016) 117:501-7.
Askenase PW et al.
Ann N Y Acad Sci (2015) 1362:200-14.
Ren A et al.
Cell Rep (2015) 13:1800-13.
Alterman JF et al.
Hydrophobically modified siRNAs silence Huntingtin mRNA in primary neurons and mouse brain.
Mol Ther Nucleic Acids (2015) 4:e266.
Kalani MY et al.
Rare variants in cardiomyopathy genes associated with stress-induced cardiomyopathy.
Neurosurgery (2016) 78:835-43.
Shaikh AY et al.
Crit Pathw Cardiol (2015) 14:157-65.
Previs RA et al.
Mol Cancer Ther (2015) 14:2677-86.
Bucur O et al.
An updated h-index measures both the primary and total scientific output of a researcher.
Discoveries (2015) 3:3.
Wei S & Williams Z.
Rapid short-read sequencing and aneuploidy detection using MinION nanopore technology.
Genetics (2016) 202:37-44.
Pradeep S et al.
Erythropoietin stimulates tumor growth via EphB4.
Cancer Cell (2015) 28:610-22.
Kosutic M et al.
Angew Chem Int Ed Engl (2015) 54:15128-33.
Yamamoto N et al.
Immunology (2016) 147:97-113.
Giza DE, Vasilescu C & Calin GA.
Key principles of miRNA involvement in human diseases.
Discoveries (Craiova) (2014) 2:e34.
Ohtsuka M et al.
MicroRNA processing and human cancer.
J Clin Med (2015) 4:1651-67.
Ferrajoli A et al.
EBioMedicine (2015) 2:572-82.
Nagaraja AS et al.
Oncogene (2016) 35:2390-7.
Matsuo K et al.
Eur J Cancer (2015) 51:1978-88.
Reyes-Gonzalez JM et al.
Targeting c-MYC in platinum-resistant ovarian cancer.
Mol Cancer Ther (2015) 14:2260-9.
Ong WQ et al.
Chem Commun (Camb) (2015) 51:13451-3.
Gharpure KM et al.
Nanotechnology: Future of oncotherapy.
Clin Cancer Res (2015) 21:3121-30.
Zhang S et al.
PLoS ONE (2015) 10:e0131833.
Ren A, Rajashankar KR & Patel DJ.
Structure (2015) 23:1375-81.
Aslan B et al.
The ZNF304-integrin axis protects against anoikis in cancer.
Nat Commun (2015) 6:7351.
Kwong RY et al.
Am J Cardiol (2015) 116:622-9.
Szabo L et al.
Genome Biol (2015) 16:126.
Boettcher M & McManus MT.
Choosing the right tool for the job: RNAi, TALEN, or CRISPR.
Li X et al.
Lowering the quantification limit of the QubitTM RNA HS assay using RNA spike-in.
BMC Mol Biol (2015) 16:9.
Wong HK et al.
Mol Ther (2015) 23:1234-47.
Related Pathway
Li K et al.
Circ Res (2015) 117:e1-e11.
Related Pathway
Miyake TM et al.
XPO1/CRM1 inhibition causes antitumor effects by mitochondrial accumulation of eIF5A.
Clin Cancer Res (2015) 21:3286-97.
Related Pathway
Liu X et al.
Cell Metab (2015) 21:584-95.
Related Pathway
Schwarzenbacher D et al.
Low spinophilin expression enhances aggressive biological behavior of breast cancer.
Oncotarget (2015) 6:11191-202.
Gilder AS et al.
J Biol Chem (2015) 290:14798-809.
Thanapprapa D Sr et al.
PTEN expression as a predictor of response to focal adhesion kinase inhibition in uterine cancer.
Mol Cancer Ther (2015) 14:1466-1475.
Ren A et al.
Structural basis for molecular discrimination by a 3′,3′-cGAMP sensing riboswitch.
Cell Rep (2015) 11:1-12.
Ling H et al.
The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis.
Gut (2016) 65:977-989.
Neilan TG et al.
Late gadolinium enhancement among survivors of sudden cardiac arrest.
JACC Cardiovasc Imaging (2015) 8:414-423.
Huan T et al.
Genome-wide identification of microRNA expression Quantitative Trait Loci.
Nat Commun (2015) 6:6601.
Martinez GJ et al.
The transcription factor NFAT promotes exhaustion of activated CD8(+) T cells.
Immunity (2015) 42:265-78.
Wei X, Liu X & Rosenzweig A.
What do we know about the cardiac benefits of exercise?
Trends Cardiovasc Med (2015) 25:529-36.
Koupenova M et al.
Arterioscler Thromb Vasc Biol (2015) 35:1030-7.
Cox JE et al.
Proc Natl Acad Sci U S A (2015) 112:1856-61.
Ling H et al.
Junk DNA and the long non-coding RNA Twist in cancer genetics.
Oncogene (2015) 34:5003-11.
Bodhankar S et al.
Metab Brain Dis (2015) 30:911-924.
Yao C et al.
Circulation (2015) 131:536-49.
Yang X et al.
New ways to successfully target tumor vasculature in ovarian cancer.
Curr Opin Obstet Gynecol (2015) 27:58-65.
Pusic AD et al.
Spreading depression transiently disrupts myelin via interferon-gamma signaling.
Exp Neurol (2015) 264:43-54.
Koupenova M & Freedman JE.
Platelets: the unsung hero of the immune response.
J Thromb Haemost (2015) 13:268-70.
Bottsford-Miller J et al.
Differential platelet levels affect response to taxane-based therapy in ovarian cancer.
Clin Cancer Res (2015) 21:602-10.
Dotson AL et al.
J Neuroimmunol (2015) 278:289-98.
Wen Y et al.
Clin Cancer Res (2015) 21:448-59.
Ren A et al.
In-line alignment and Mg(2)(+) coordination at the cleavage site of the env22 twister ribozyme.
Nat Commun (2014) 5:5534.
Previs RA et al.
Clin Cancer Res (2015) 21:955-61.
van den Beucken T et al.
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER.
Nat Commun (2014) 5:5203.
Related Pathway
Leung CS et al.
Nat Commun (2014) 5:5092.
Related Pathway
del C. Monroig P et al.
Small molecule compounds targeting miRNAs for cancer therapy.
Adv Drug Deliv Rev (2015) 81:104-16.
Gonzalez-Villasana V et al.
Mol Cancer Ther (2014) 13:2583-94.
Quesenberry PJ, Goldberg LR & Dooner MS.
Concise reviews: A stem cell apostasy: a tale of four H words.
Stem Cells (2015) 33:15-20.
Mata IF et al.
APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease.
JAMA Neurol (2014) 71:1405-12.
Han C et al.
Cell Rep (2014) 8:1447-60.
Related Pathway
Maguire CA et al.
Gene therapy for the nervous system: Challenges and new strategies.
Neurotherapeutics (2014) 11:817-39.
Berindan-Neagoe I et al.
MicroRNAome genome: a treasure for cancer diagnosis and therapy.
CA Cancer J Clin (2014) 64:311-36.
Ren A & Patel DJ.
c-di-AMP binds the ydaO riboswitch in two pseudo-symmetry-related pockets.
Nat Chem Biol (2014) 10:780-6.
Davis AN, Afshar-Kharghan V & Sood AK.
Platelet effects on ovarian cancer.
Semin Oncol (2014) 41:378-84.
Pradeep S et al.
Hematogenous metastasis of ovarian cancer: Rethinking mode of spread.
Cancer Cell (2014) 26:77-91.
Murphy SJ et al.
Sex differences in microRNA expression during development in rat cortex.
Neurochem Int (2014) 77:24-32.
Wu SY et al.
RNAi therapies: Drugging the undruggable.
Sci Transl Med (2014) 6:240ps7.
Nery FC et al.
Microfluidic platform to evaluate migration of cells from patients with DYT1 dystonia.
J Neurosci Methods (2014) 232:181-8.
Bauer CA et al.
Dynamic Treg interactions with intratumoral APCs promote local CTL dysfunction.
J Clin Invest (2014) 124:2425-40.
Jiang H et al.
Cancer Immunol Res (2014) 2:789-99.
Yang L et al.
Mol Syst Biol (2014) 10:728.
Related Pathway
Freedman JE.
Inherited dysfunctional nitric oxide signaling and the pathobiology of atherothrombotic disease.
Circ Res (2014) 114:1372-3.
Gharpure KM et al.
Mol Cancer Ther (2014) 13:1750-7.
Tucker SL et al.
Clin Cancer Res (2014) 20:3280-8.
Hu W et al.
Notch3 pathway alterations in ovarian cancer.
Cancer Res (2014) 74:3282-93.
Related Pathway
Pusic KM et al.
Glia (2014) 62:1176-94.
Patel T & Harnois D.
Assessment of response to therapy in hepatocellular carcinoma.
Ann Med (2014) 46:130-7.
Zhang H et al.
Breast Cancer Res (2014) 16:R36.
Cholerton BA et al.
Evaluation of mild cognitive impairment subtypes in Parkinson’s disease.
Mov Disord (2014) 29:756-64.
Jiang H et al.
Am J Pathol (2014) 184:1355-68.
Wu SY et al.
Nat Commun (2014) 5:3459.
Cho MS et al.
Autocrine effects of tumor-derived complement.
Cell Rep (2014) 6:1085-95.
Lusardi TA et al.
MicroRNA responses to Focal Cerebral Ischemia in male and female mouse brain.
Front Mol Neurosci (2014) 7:11.
Dalton HJ et al.
Monocyte subpopulations in angiogenesis.
Cancer Res (2014) 74:1287-93.
Morey R & Laurent LC.
Getting off the ground state: X chromosome inactivation knocks down barriers to differentiation.
Cell Stem Cell (2014) 14:131-2.
Beaulieu LM et al.
Arterioscler Thromb Vasc Biol (2014) 34:552-64.
Related Pathway
Ngamruengphong S & Patel T.
Molecular evolution of genetic susceptibility to hepatocellular carcinoma.
Dig Dis Sci (2014) 59:986-91.
Yao C et al.
Sex- and age-interacting eQTLs in human complex diseases.
Hum Mol Genet (2014) 23:1947-56.
Jun HJ, Bronson RT & Charest A.
Inhibition of EGFR induces a c-MET-driven stem cell population in glioblastoma.
Stem Cells (2014) 32:338-48.
Aslan B et al.
Nanotechnology in cancer therapy.
J Drug Target (2013) 21:904-13.
Pecot CV et al.
Tumour angiogenesis regulation by the miR-200 family.
Nishimura M et al.
Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment.
Cancer Discov (2013) 3:1302-15.
Saugstad JA.
MicroRNAs as effectors of brain function.
Stroke (2013) 44:S17-9.